HNN3.0
Register
Register
Register

Project cooperationUpdated on 26 January 2026

Préclinically confirmed slow release capsules for cancer

CNRS senior scientist #Slow release capsules for cancer at Medicaps CNRS

Nancy, France

About

Local chemotherapy represents a growing trend to maximize local tumor control with minimal systemic toxicity but requires a new drug delivery system for treatment efficiency and ease of administration. Microcapsules are tailored drug delivery vehicles capable of transporting pure doses of chemotherapeutic agents into cancerous tumors while sparing healthy cells at distance from the tumors. Microcapsules have shown great promise in changing the face of oncology, as they have a tumor-specific targeting and sustained drug delivery capability that overcomes the limitations of traditional chemotherapy.

=> Our capsules can be used as “shuttles” to deliver specific molecules on site.

Organisation

Medicaps CNRS

University

Nancy, France

Similar opportunities

  • Project cooperation

    ELOHIMED is a French Start-up specializing in the research and development of new drugs and bioactive compositions against cancer.

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Guy MONKAM

    Pharmacist

    Fort-de-France, Martinique

  • Project cooperation

    TRACE PDX platform

    Maria Francesca Baietti

    Manager PDX platform at KU Leuven

    Leuven, Belgium

  • Project cooperation

    Cancer, Fibrosis and Coagulation

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Alessandra Metelli

    Researcher at IRCCS Regina Elena National Cancer Institute

    Rome, Italy